English A A A

2008


Publikasjoner med hel eller delvis tilknytning til Revmatologisk avdeling og/eller seksjon for revmatologi i 2008

  1. Brun JG, Jonsson R. Sjögrens syndrom. Norsk Epidemiologi 2008;18:67-72.
  2. Brunborg LA, Madland TM, Lind RA, Arslan G, Berstad A, Froyland L. Effects of short-term oral administration of dietary marine oils in patients with inflammatory bowel disease and joint pain: a pilot study comparing seal oil and cod liver oil. Clin Nutr 2008;27:614-22.
  3. Delaleu N, Immervoll H, Cornelius J, Jonsson R. Biomarker profiles in serum and saliva of experimental Sjogren's syndrome: associations with specific autoimmune manifestations. Arthritis Res Ther 2008;10:R22.
  4. Delaleu N, Jonsson MV, Appel S, Jonsson R. New concepts in the pathogenesis of Sjogren's syndrome. Rheum Dis Clin North Am 2008;34:833-45, vii.
  5. Delaleu N, Jonsson R. Altered fractalkine cleavage results in an organ-specific 17 kDa fractalkine fragment in salivary glands of NOD mice. Arthritis Res Ther 2008;10:114.
  6. Delaleu N, Madureira AC, Immervoll H, Jonsson R. Inhibition of experimental Sjogren's syndrome through immunization with HSP60 and its peptide amino acids 437-460. Arthritis Rheum 2008;58:2318-28.
  7. Elshorbagy AK, Nurk E, Gjesdal CG, Tell GS, Ueland PM, Nygard O, Tverdal A, Vollset SE, Refsum H. Homocysteine, cysteine, and body composition in the Hordaland Homocysteine Study: does cysteine link amino acid and lipid metabolism? Am J Clin Nutr 2008;88:738-46.
  8. Forsen L, Berntsen GK, Meyer HE, Tell GS, Fonnebo V. Differences in precision in bone mineral density measured by SXA and DXA: the NOREPOS study. Eur J Epidemiol 2008;23:615-24.
  9. Gjesdal CG, Halse JI, Eide GE, Brun JG, Tell GS. Impact of lean mass and fat mass on bone mineral density: The Hordaland Health Study. Maturitas 2008;21:21.
  10. Haldorsen K, Moen K, Jacobsen H, Jonsson R, Brun JG. Exocrine function in primary Sjogren syndrome: natural course and prognostic factors. Ann Rheum Dis 2008;67:949-54.
  11. Haugen AJ, Peen E, Hulten B, Johannessen AC, Brun JG, Halse AK, Haga HJ. Estimation of the prevalence of primary Sjogren's syndrome in two age-different community-based populations using two sets of classification criteria: the Hordaland Health Study. Scand J Rheumatol 2008;37:30-4.
  12. Isaksen K, Jonsson R, Omdal R. Anti-CD20 treatment in primary Sjogren's syndrome. Scand J Immunol 2008;68:554-64.
  13. Madland TM. Psoriasisartritt. Norsk Epidemiologi 2008;18:16-20.
  14. Omsland TK, Emaus N, Gjesdal CG, Falch JA, Tell GS, Forsen L, Berntsen GK, Meyer HE. In vivo and in vitro comparison of densitometers in the NOREPOS study. J Clin Densitom 2008;11:276-82.
  15. Omsland TK, Gjesdal CG, Emaus N, Tell GS, Meyer HE. Regional differences in hip bone mineral density levels in Norway: the NOREPOS study. Osteoporos Int 2008.
  16. Szodoray P, Nakken B, Gaal J, Jonsson R, Szegedi A, Zold E, Szegedi G, Brun JG, Gesztelyi R, Zeher M, Bodolay E. The complex role of vitamin D in autoimmune diseases. Scand J Immunol 2008;68:261-9.
  17. Vesterhus M, Raeder H, Aurlien H, Gjesdal CG, Bredrup C, Holm PI, Molven A, Bindoff L, Berstad A, Njolstad PR. Neurological features and enzyme therapy in patients with endocrine and exocrine pancreas dysfunction due to CEL mutations. Diabetes Care 2008;31:1738-40.

Sist endret: 21.3.2012